Tuba Erürker Öztürk

Dr. Tuba Erürker Öztürk

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2023 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
PDF file
TÖTuba Erürker Öztürk
Tuba Erürker Öztürk
Introduction: Artificial intelligence (AI) has made a big difference and is used in many different sectors also in medicine. We sought to identify the areas of interest and potential future directions for AI in the field of colonoscopy imaging and colonic diseases by utilizing bibliometrics to analyze the previous 50 years' worth of changes on this topic. Material and methods: Using the Web of Knowledge (WOS) database, we searched for articles published from 1970 to 2021 using the keywords related to colonoscopy imaging/colonic diseases and AI. The retrieved articles were analysed with bibliometric methods. Results: A total of 278 documents were analyzed in this study. The earliest article was published in 1997 and the vast majority of the documents were published in 2021 (n=81). There was a growth in publications number in the last 5 years. The documents were cited 3054 times in total and had 10.99 citations per document. The main Hirsch (H) index of the documents was 27. A total of 41 countries contributed to the literature. The United States of America (USA), the People’s Republic of China, and England were the leading countries on this topic. Also, England had the highest number of citations (total of 974 citations, 31.42 per document) and the USA publications had the highest H index. Discussion: Artificial intelligence facilitates diagnosis and treatment possibilities, especially in the field of health. Especially the use of artificial intelligence in colonoscopic imaging reduces the risk of missing a possible polyp or a mucosal pathology. The integration of artificial intelligence into imaging methods has been the most in the last 5 years. Most studies on this subject have been done in the USA. Conclusion: Our research may offer a historical perspective on the development of AI in colorectal diseases. The documents were limited to some developing countries.

6 October 2023 in Hamidiye Medical Journal
Verified
Journal Article
Closed access
TÖTuba Erürker Öztürk
Tuba Erürker Öztürk
AKAli Keskin
Ali Keskin
CÖCan Özlü
Can Özlü
İSİsmail Sarı
İsmail Sarı
SHSibel Hacioglu
Sibel Hacioglu
IGİlKay Güler
İlKay Güler

12 June 2023 in Dicle Tıp Dergisi
Verified
Journal Article
Open access
PDF file
TÖTuba Erürker Öztürk
Tuba Erürker Öztürk
MKMurat Kiyici
Murat Kiyici
MGMacit Gülten
Macit Gülten
EDEnver Dolar
Enver Dolar
SGSelim Gürel
Selim Gürel
FEFatih Eren
Fatih Eren
Objective: To show the importance of tissue Cytomegalovirus (CMV) PCR to diagnose CMV infection in patients with treatment-resistant ulcerative colitis. Methods: Fifteen patients who had previously been diagnosed as ulcerative colitis with clinical, endoscopic, histological, and radiological criteria and who had referred to our clinic with acute exacerbation who were diagnosed with CMV colitis and received CMV treatment, were evaluated retrospectively. After the demographic and clinical characteristics of the patients were noted, Mayo scores were evaluated to determine ulcerative colitis activity. Patients' age, gender, laboratory values, type of colitis, and Mayo scores were recorded. Biopsy results, CMV IgM, serum, and tissue CMV DNA levels were noted. Descriptive statistical parameters of the demographical data were calculated. Results: Eleven of the patients were male, and four were female. The mean age of the patients was 42±11,3. The mean duration of the disease was 28±46 months. Twelve patients had pancolitis, and three patients had distal colitis. All patients' Mayo score was 12 points. All patients were steroid-resistant, and none had previously received biological agent therapy. 7 of 15 patients had serum CMV DNA levels over 1000 copies/mL. Tissue CMV DNA levels of 8 patients were found higher than 250 copies/mg, although serum CMV DNA levels were below 1000 copies/mL. Pathology samples of 11 patients were evaluated, and CMV inclusion bodies were not detected. All patients received ganciclovir for CMV treatment. After treatment, CMV DNA of all patients was negative, and diarrhea and inflammation markers were reduced. Conclusion: For the diagnosis of CMV, CMV-PCR in colon tissue specimens should also be considered in addition to endoscopic appearance and serum CMV DNA levels.

11 May 2022
Verified
Book
Open access
PDF file
YTYakup Tatar
Yakup Tatar
ETEmre Turgut
Emre Turgut
SUSevi Karabulut Uzunçakmak
Sevi Karabulut Uzunçakmak
PBPinar Gundogan Bozdag
Pinar Gundogan Bozdag
FDFadime Demir
Fadime Demir
DÇDeniz Çetinkünar
Deniz Çetinkünar
Kitabımızın oluşturulmasında en belirleyici etken olan “Bilimsel düşünce ve üretmek” adına bizleri yetiştiren ve bu vizyonu kazandıran; fakülte sıralarından asistanlığımızın sonuna ve uzmanlık yıllarımıza dek katkıları olan, bizlere bu yolu açan çok değerli hocalarımıza öncelikle teşekkürlerimi sunarım. Mesleki olarak yararlandığımız ve bizlere faydalı olan uluslararası branş kitaplarının yanında, ülke kaynaklarımız ve tıp dünyamıza ait tecrübelerin, bilimsel çalışmaların referans alınarak meslektaşlarımıza yansıtıldığı ve katkı sunmasını amaçladığımız bu çalışmamızın değerli meslektaşlarımız ve hocalarımıza faydalı olmasını dilerim.

29 October 2020 in Research Square
Verified
Preprint
Open access
PDF file
TÖTuba Erürker Öztürk
Tuba Erürker Öztürk
SGSeli̇m Gürel
Seli̇m Gürel
AOAyşegül Oruç
Ayşegül Oruç
AEAlpaslan Ersoy
Alpaslan Ersoy
Background Interferon and/or ribavirin treatment previously used in the treatment of HCV cannot be used effectively in hemodialysis patients due to dose adjustment and drug-related side effects. The direct-acting antiviral combination (DAA) is reported to be effective in hemodialysis patients. We evaluated the effectiveness of DAA in hemodialysis patients with chronic hepatitis C .Method Twenty hemodialysis patients with chronic hepatitis C kept under surveillance at the policlinic of the Department of Gastroenterology, … , … between 2016 and 2018 were evaluated retrospectively. Results Of the 20 patients, 12 were male, and 8 were female. The average age of the patients was 50,7 ± 8,6. Six patients had no treatment experience. A total of 14 patients (70%) had previously been treated with interferon and/or ribavirin, but SVR could not be achieved. Genotype Ib was detected in 14 patients (70%), genotype Ia was found in 4 patients (20%), and genotype I was detected in 2 patients (10%). Two of the patients were cirrhotic (10%) and the Child-Pugh Score (CPS) was A. Treatment was discontinued in 2 patients due to thrombus formation in AV fistula in the first month of DAA treatment. SVR12 was evaluated in 14 out of 18 patients and found to be 100%. One of the ten patients whose SVR24 was evaluated had a relapse. This is similar to SVR24 in the average population.Conclusions OBV/PTV/r + DSV is an easily appropriate and effective regimen for the treatment of hemodialysis patients with chronic hepatitis C.

14 April 2022
Verified
Book
Closed access
PDF file
TÖTuba Erürker Öztürk
Tuba Erürker Öztürk
A(Ayşe Kefeli (Ed)
Ayşe Kefeli (Ed)
FEFatih Eren
Fatih Eren
Bazen sıkça rastlanılan şikayetler çok iyi bilindiği düşünülerek gözardı edilebilmektedir. Bazı hastaların yaşam kalitesini etkileyen hastalıkların dile getirilmesinde ya da tanı konulmasında zorlanılmaktadır. Bir bütünün içinde her şeyden bahsedilirken özelleşmiş sistemlere yer daha az verilmektedir. Bu kitap ile pankreas ve hastalıkları tüm bilinmeyenleri ve ayrıntılarıyla aydınlatılmaya çalışılmıştır. Pankreas hastalıklarına multidisipliner yaklaşım oluşturulmuştur.